GSK ads for Avodart are misleading, says FDA
Consumer ads in support of GSK's prostate drug Avodart overstate its efficacy and present misleading claims, the FDA said.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.